查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451893

2024-2032 年按类别、应用（社区获得性呼吸道感染、泌尿道感染、牙科等）、药物来源、活性谱、药物类型和地区分类的口服抗生素市场报告

Oral Antibiotics Market Report by Class, Application (Community-acquired Respiratory Tract Infections, Urinary Tract Infections, Dental and Others), Drug Origin, Spectrum of Activity, Drug Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球口服抗生素市场规模达到204.014亿美元。展望未来， IMARC Group预计到2032年，市场规模将达到276.122亿美元，2024-2032年复合年增长率（CAGR）为3.32%。传染病的日益流行、老年人口的扩大、针对抗药性细菌的有效治疗的需求不断增加，以及个人化医疗和基因组学的成长趋势是推动市场的一些关键因素。

口服抗生素是主要用于抑制细菌生长或消除体内细菌的药剂。它们通常透过口腔服用，并在广泛的医疗应用中使用。口服抗生素治疗的感染类型各不相同，包括皮肤、耳朵、喉咙和泌尿道感染等常见疾病，以及某些类型的肺炎等更复杂的疾病。这些抗生素分为不同的类别，每种抗生素都有不同的作用机转。一些常用的处方类别包括青霉素类、氟喹诺酮类、四环素类和大环内酯类。每一类针对不同类型的细菌，对特定细菌感染更有效。例如，青霉素广泛用于治疗链球菌感染，而氟喹诺酮类药物则可用于对抗某些革兰氏阴性细菌。因此，口服抗生素是现代医疗保健的关键要素，并被医疗保健专业人员广泛使用，以成功治疗多种细菌感染。

口服抗生素市场趋势：

传染病的日益普及以及公众对这些疾病的可用治疗方案的认识不断提高，是支持市场成长的主要因素。此外，越来越多的老年人口更容易发生此类感染，这是推动市场成长的另一个主要因素。此外，抗生素管理计画增加，旨在鼓励抗生素的广泛使用，减缓抗生素抗药性的出现，并确保这些药物的长期有效性。同时，日益严重的抗生素抗药性问题迫使研究人员和製药公司修改现有类别并开发能够治疗多重抗药性细菌的新抗生素，从而加快产品采用率。此外，领先的製药公司和研究机构正在药物发现过程中利用人工智慧（AI）和机器学习（ML）来预测细菌抗药性模式，了解药物与细菌的相互作用，并加快新型抗生素的发现。与此一致的是，个人化医疗和基因组学的出现促进了市场的成长，其中个人化医疗和基因组学涉及透过考虑患者的基因组成等因素来为个别患者量身定制抗生素治疗，以提高治疗效果并最大限度地减少副作用。其他因素，包括对抗药性细菌有效治疗的需求不断增加、医疗基础设施的改善、新型口服抗生素的不断推出以及对研发（R＆D）活动的​​大量投资，预计也将推动未来市场的成长年。

本报告回答的关键问题：

  • 迄今为止，全球口服抗生素市场表现如何，未来几年将如何表现？
  • 全球口服抗生素市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球口服抗生素市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的口服抗生素市场？
  • 市场按类别划分是怎么样的？
  • 口服抗生素市场中哪一类最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 口服抗生素市场中最具吸引力的应用是什么？
  • 根据药品来源分類的市场是怎么样的？
  • 口服抗生素市场上最具吸引力的药源是哪一个？
  • 依活动范围分類的市场是怎么样的？
  • 口服抗生素市场中最具吸引力的活动范围是什么？
  • 根据药物类型分類的市场是怎么样的？
  • 口服抗生素市场上最具吸引力的药物类型是什么？
  • 全球口服抗生素市场竞争格局如何？
  • 全球口服抗生素市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球口服抗生素市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依类别

  • β内酰胺和β内酰胺酶抑制剂
    • 市场走向
    • 关键环节
      • 青霉素
      • 头孢菌素
      • 其他的
    • 市场预测
  • 奎诺酮类
    • 市场走向
    • 市场预测
  • 大环内酯
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 社区型呼吸道感染 (CARTI)
    • 市场走向
    • 关键环节
      • 上呼吸道感染 (URTI)
      • 下呼吸道感染 (LRTI)
    • 市场预测
  • 泌尿道感染 (UTI)
    • 市场走向
    • 市场预测
  • 牙科
    • 市场走向
    • 关键环节
      • 组合
      • 单一疗法
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依药物来源

  • 自然的
    • 市场走向
    • 市场预测
  • 半合成
    • 市场走向
    • 市场预测
  • 合成的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依活动范围

  • 广效抗生素
    • 市场走向
    • 市场预测
  • 窄谱抗生素
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依药物类型

  • 品牌化
    • 市场走向
    • 市场预测
  • 泛型
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bayer AG
    • Cipla Inc
    • Gilead Sciences Inc
    • Janssen Inc. (Johnson & Johnson Services, Inc)
    • Pfizer Inc.
    • Roche Holding AG
    • Sun Pharmaceutical Industries Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A8355

The global oral antibiotics market size reached US$ 20,401.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 27,612.2 Million by 2032, exhibiting a growth rate (CAGR) of 3.32% during 2024-2032. The increasing prevalence of infectious diseases, expanding geriatric population, escalating demand for effective treatments against drug-resistant bacteria, and the growing trend of personalized medicine and genomics represent some of the key factors driving the market.

Oral antibiotics are pharmaceutical agents primarily prescribed to inhibit bacterial growth or eliminate bacteria from the body. They are usually taken by mouth and are utilized across a wide range of medical applications. The types of infections treated by oral antibiotics vary and include common ailments such as skin, ear, throat, and urinary tract infections and more complex conditions like certain types of pneumonia. These antibiotics are categorized into different classes, each with a distinct mechanism of action. Some commonly prescribed classes include penicillins, fluoroquinolones, tetracyclines, and macrolides. Each class targets different types of bacteria and is more effective for specific bacterial infections. For instance, penicillins are widely used for streptococcal infections, while fluoroquinolones may be chosen to combat certain gram-negative bacteria. As a result, oral antibiotics are a key element of modern healthcare and are widely prescribed by healthcare professionals to enable the successful treatment of numerous bacterial infections.

Oral Antibiotics Market Trends:

The increasing prevalence of infectious diseases and the rising public awareness about the available treatment options for these conditions represent the primary factors supporting market growth. Moreover, the expanding geriatric population that is more susceptible to developing such infections is another major factor fueling the market growth. In addition, there has been a rise in antibiotic stewardship programs aimed at encouraging the widespread use of antibiotics, slowing down the emergence of antibiotic resistance, and ensuring the prolonged effectiveness of these drugs. Along with this, the growing issue of antibiotic resistance has compelled researchers and pharmaceutical companies to modify existing classes and develop new antibiotics capable of treating multi-drug resistant bacteria, thereby accelerating the product adoption rate. Furthermore, the leading pharmaceutical companies and research institutes are leveraging artificial intelligence (AI) and machine learning (ML) in the drug discovery process to predict bacterial resistance patterns, understand drug-bacteria interactions, and expedite the discovery of novel antibiotics. In line with this, the emergence of personalized medicine and genomics, which involves tailoring antibiotic treatment to individual patients by considering factors such as their genetic makeup to enhance treatment effectiveness and minimize side effects, has catalyzed market growth. Other factors, including escalating demand for effective treatments against drug-resistant bacteria, improving healthcare infrastructure, the continual launch of novel oral antibiotics, and heavy investments in research and development (R&D) activities, are also anticipated to propel the market growth in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oral antibiotics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the class, application, drug origin, spectrum of activity, and drug type.

Class Insights:

Beta Lactam and Beta Lactamase Inhibitors

Penicillin

Cephalosporin

Others

Quinolone

Macrolide

Others

The report has provided a detailed breakup and analysis of the oral antibiotics market based on the class. This includes beta lactam and beta lactamase inhibitors (penicillin, cephalosporin, and others), quinolone, macrolide, and others. According to the report, beta lactam and beta lactamase inhibitors represented the largest segment.

Application Insights:

Community-acquired Respiratory Tract Infections (CARTIs)

Upper Respiratory Tract Infections (URTI)

Lower Respiratory Tract Infections (LRTIs)

Urinary Tract Infections (UTIs)

Dental

Combination

Monotherapies

Others

A detailed breakup and analysis of the oral antibiotics market based on the application has also been provided in the report. This includes community-acquired respiratory tract infections (upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTIs)), urinary tract infections (UTIs), dental (combination and monotherapies), and others. According to the report, urinary tract infections (UTIs) accounted for the largest market share.

Drug Origin Insights:

Natural

Semisynthetic

Synthetic

The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug origin. This includes natural, semisynthetic, and synthetic. According to the report, synthetic represented the largest segment.

Spectrum of Activity Insights:

Broad-spectrum Antibiotic

Narrow Spectrum Antibiotic

A detailed breakup and analysis of the oral antibiotics market based on the spectrum of activity has also been provided in the report. This includes broad-spectrum antibiotic and narrow spectrum antibiotic.

Drug Type Insights:

Branded

Generics

The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug type. This includes branded and generics.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific was the largest market for oral antibiotics. Some of the factors driving the Asia-Pacific oral antibiotics market included its aging population, growing burden of infectious diseases, high healthcare expenditure, the presence of various key players, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral antibiotics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bayer AG, Cipla Inc., Gilead Sciences Inc., Janssen Inc. (Johnson & Johnson Services, Inc.), Pfizer Inc., Roche Holding AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global oral antibiotics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global oral antibiotics market?
  • What is the impact of each driver, restraint, and opportunity on the global oral antibiotics market?
  • What are the key regional markets?
  • Which countries represent the most attractive oral antibiotics market?
  • What is the breakup of the market based on the class?
  • Which is the most attractive class in the oral antibiotics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the oral antibiotics market?
  • What is the breakup of the market based on the drug origin?
  • Which is the most attractive drug origin in the oral antibiotics market?
  • What is the breakup of the market based on the spectrum of activity?
  • Which is the most attractive spectrum of activity in the oral antibiotics market?
  • What is the breakup of the market based on the drug type?
  • Which is the most attractive drug type in the oral antibiotics market?
  • What is the competitive structure of the global oral antibiotics market?
  • Who are the key players/companies in the global oral antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oral Antibiotics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Class

  • 6.1 Beta Lactam and Beta Lactamase Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Penicillin
      • 6.1.2.2 Cephalosporin
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Quinolone
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Macrolide
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Community-acquired Respiratory Tract Infections (CARTIs)
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Upper Respiratory Tract Infections (URTI)
      • 7.1.2.2 Lower Respiratory Tract Infections (LRTIs)
    • 7.1.3 Market Forecast
  • 7.2 Urinary Tract Infections (UTIs)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dental
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Combination
      • 7.3.2.2 Monotherapies
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Drug Origin

  • 8.1 Natural
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Semisynthetic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Synthetic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Spectrum of Activity

  • 9.1 Broad-spectrum Antibiotic
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Narrow Spectrum Antibiotic
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Drug Type

  • 10.1 Branded
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Generics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bayer AG
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Cipla Inc
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Gilead Sciences Inc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Janssen Inc. (Johnson & Johnson Services, Inc)
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Pfizer Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Roche Holding AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Sun Pharmaceutical Industries Ltd
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Teva Pharmaceutical Industries Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Oral Antibiotics Market: Major Drivers and Challenges
  • Figure 2: Global: Oral Antibiotics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Oral Antibiotics Market: Breakup by Class (in %), 2023
  • Figure 5: Global: Oral Antibiotics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oral Antibiotics Market: Breakup by Drug Origin (in %), 2023
  • Figure 7: Global: Oral Antibiotics Market: Breakup by Spectrum of Activity (in %), 2023
  • Figure 8: Global: Oral Antibiotics Market: Breakup by Drug Type (in %), 2023
  • Figure 9: Global: Oral Antibiotics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oral Antibiotics (Quinolone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oral Antibiotics (Quinolone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oral Antibiotics (Macrolide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oral Antibiotics (Macrolide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oral Antibiotics (Other Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oral Antibiotics (Other Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oral Antibiotics (Dental) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oral Antibiotics (Dental) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oral Antibiotics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oral Antibiotics (Other Applications) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 26: Global: Oral Antibiotics (Natural) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Oral Antibiotics (Natural) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Oral Antibiotics (Semisynthetic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Oral Antibiotics (Semisynthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Oral Antibiotics (Synthetic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Oral Antibiotics (Synthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Oral Antibiotics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Oral Antibiotics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Oral Antibiotics (Generics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Oral Antibiotics (Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Oral Antibiotics Market: Sales Value (in Million US$),2018 & 2023
  • Figure 41: North America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Oral Antibiotics Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Oral Antibiotics Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Oral Antibiotics Industry: Value Chain Analysis
  • Figure 91: Global: Oral Antibiotics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oral Antibiotics Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Oral Antibiotics Market Forecast: Breakup by Class (in Million US$), 2024-2032
  • Table 3: Global: Oral Antibiotics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oral Antibiotics Market Forecast: Breakup by Drug Origin (in Million US$), 2024-2032
  • Table 5: Global: Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (in Million US$), 2024-2032
  • Table 6: Global: Oral Antibiotics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 7: Global: Oral Antibiotics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Oral Antibiotics Market: Competitive Structure
  • Table 9: Global: Oral Antibiotics Market: Key Players